Gong; Baoqing

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gong; Baoqing.The latest application filed is for "chemical process for preparing pyrimidine derivatives and intermediates thereof".

Company Profile

1.19.36

Gong; Baoqing - Basel CH
Gong; Baoqing - Morris Plains NJ US
Gong; Baoqing - Shoreline WA
Gong; Baoqing - Emeryville CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chemical Process for Preparing Pyrimidine Derivatives and Intermediates Thereof App 20200039935 - Davis; Mark Clinton ; et al.	2020-02-06
Chemical Process for Preparing Pyrimidine Derivatives and Intermediates Thereof App 20180057457 - Davis; Mark Clinton ; et al.	2018-03-01
Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo- [2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof Grant 9,868,739 - Calienni , et al. January 16, 2	2018-01-16
Crystalline Forms Of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propan- E-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine App 20160175305 - Feng; Lili ; et al.	2016-06-23
Manufacturing process for pyrimidine derivatives Grant 9,359,326 - Calienni , et al. June 7, 2	2016-06-07
Crystalline forms of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propan- e-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine Grant 9,309,229 - Feng , et al. April 12, 2	2016-04-12
Salt(s) Of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo- [2,3-d]pyrimidine-6-carboxylic Acid Dimethylamide And Processes Of Making Thereof App 20160039832 - Calienni; John Vincent ; et al.	2016-02-11
Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo- [2,3-D]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof Grant 9,193,732 - Calienni , et al. November 24, 2	2015-11-24
Manufacturing Process For Pyrimidine Derivatives App 20150232446 - Calienni; John Vincent ; et al.	2015-08-20
Compounds For The Treatment Of Conditions Associated With Dgat1 Activity App 20150166522 - CAPACCI-DANIEL; Christina ; et al.	2015-06-18
Salt(s) Of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo- [2,3-d]pyrimidine-6-carboxylic Acid Dimethylamide And Processes Of Making Thereof App 20150099760 - Calienni; John Vincent ; et al.	2015-04-09
Compounds for the treatment of conditions associated with DGAT1 activity Grant 8,987,459 - Capacci-Daniel , et al. March 24, 2	2015-03-24
Compounds For The Treatment Of Conditions Associated With Dgat1 Activity App 20140200246 - CAPACCI-DANIEL; Christina ; et al.	2014-07-17
Crystalline Forms Of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propan- E-2-sulfonyl)-phenyl]-pyrimidine-2, 4-diamine App 20130274279 - Feng; Lili ; et al.	2013-10-17
Manufacturing Process For Pyrimidine Derivatives App 20130225571 - Calienni; John Vincent ; et al.	2013-08-29
Salt(s) Of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo- [2,3-d]pyrimidine-6-carboxylic Acid Dimethylamide And Processes Of Making Thereof App 20130217698 - Calienni; John Vincent ; et al.	2013-08-22
Salt(s) Of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo- [2,3-d]pyrimidine-6-carboxylic Acid Dimethylamide And Processes Of Making Thereof App 20120115878 - Calienni; John Vincent ; et al.	2012-05-10
Lpaat-beta Inhibitors And Uses Thereof App 20100189726 - BONHAM; Lynn ; et al.	2010-07-29
2-Amino-7,8-dihydro-6H-pyrido[4,3-D]pyrimidin-5-ones App 20100004237 - Machakewski; Timothy D. ; et al.	2010-01-07
Aryl triazines as LPAAT-.beta. inhibitors and uses thereof Grant 7,618,968 - Bhatt , et al. November 17, 2	2009-11-17
LPAAT-.beta. inhibitors and uses thereof Grant 7,608,620 - Bonham , et al. October 27, 2	2009-10-27
Pyrimidines And Uses Thereof App 20090099183 - BHATT; Rama ; et al.	2009-04-16
Pyrimidines and uses thereof Grant 7,419,984 - Bhatt , et al. September 2, 2	2008-09-02
Aryl triazines as LPAAT-beta inhibitors and uses thereof App 20080064700 - Bhatt; Rama ; et al.	2008-03-13
Aryl triazines as LPAAT-.beta. inhibitors and uses thereof Grant 7,291,616 - Bhatt , et al. November 6, 2	2007-11-06
Uses of tricyclic compounds Grant 7,247,630 - Gong , et al. July 24, 2	2007-07-24
LPAAT-.beta. inhibitors and uses thereof Grant 7,199,238 - Bonham , et al. April 3, 2	2007-04-03
LPAAT-beta inhibitors and uses thereof App 20070072856 - Gong; Baoqing ; et al.	2007-03-29
LPAAT-.beta. inhibitors and uses thereof Grant 7,064,125 - Gong , et al. June 20, 2	2006-06-20
LPAAT-beta inhibitors and uses thereof App 20060035896 - Bonham; Lynn ; et al.	2006-02-16
Therapeutic compounds for inhibiting interleukin-12 signals and method for using same Grant 6,878,715 - Klein , et al. April 12, 2	2005-04-12
Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same App 20050049262 - Klein, J. Peter ; et al.	2005-03-03
Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same App 20050032748 - Klein, J. Peter ; et al.	2005-02-10
Pyrimidines and uses thereof App 20040204386 - Bhatt, Rama ; et al.	2004-10-14
LPAAT-beta inhibitors and uses thereof App 20040162288 - Gong, Baoqing ; et al.	2004-08-19
Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same Grant 6,774,130 - Klein , et al. August 10, 2	2004-08-10
Tricyclic compounds and their uses App 20030162801 - Gong, Baoqing ; et al.	2003-08-28
Aryl triazines as LPAAT-SS inhibitors and uses thereof App 20030153570 - Bhatt, Rama ; et al.	2003-08-14
LPAAT-beta inhibitors and uses thereof App 20030100557 - Finney, Robert ; et al.	2003-05-29
Tricyclic Fused Xanthine Compounds And Their Uses App 20020103211 - Gong, Baoqing ; et al.	2002-08-01
Therapeutic Compounds For Inhibiting Interleukin-12 Signaling And Methods For Using Same App 20020028823 - KLEIN, J. PETER ; et al.	2002-03-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.